The 1 analysts offering 12-month price forecasts for Akers Biosciences Inc have a median target of 768.00, with a high estimate of 768.00 and a low estimate of 768.00. The median estimate represents a +12,510.84% increase from the last price of 6.09.
The current consensus among 1 polled investment analysts is to Buy stock in Akers Biosciences Inc. This rating has held steady since December, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share --
Reporting Date TBD
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.